The bone morphogenetic proteins (BMPs) play a pivotal role in endochondral bone formation. Using differential display polymerase chain reaction, we have identified a novel gene, named BIG-3 (BMP-2-induced gene 3 kb), that is induced as a murine prechondroblastic cell line, MLB13MYC clone 17, acquires osteoblastic features in response to BMP-2 treatment. The 3-kilobase mRNA encodes a 34-kDa protein containing seven WD-40 repeats. Northern and Western analyses demonstrated that BIG-3 mRNA and protein were induced after 24 h of BMP-2 treatment. BIG-3 mRNA was expressed in conditionally immortalized murine bone marrow stromal cells, osteoblasts, osteocytes, and growth plate chondrocytes, as well as in primary calvarial osteoblasts. Immunohistochemistry demonstrated that BIG-3 was expressed in the osteoblasts of calvariae isolated from mouse embryos. To identify a role for BIG-3 in osteoblast differentiation, MC3T3-E1 cells were stably transfected with the full-length coding region of BIG-3 (MC3T3E1-BIG-3) cloned downstream of a cytomegalovirus promoter in pcDNA3.1. Pooled MC3T3E1-BIG-3 clones expressed alkaline phosphatase activity earlier and achieved a peak level of activity 10-fold higher than cells transfected with the empty vector (MC3T3E1-EV) at 14 days. Cyclic AMP production in response to parathyroid hormone was increased 10-and 14-fold at 7 and 14 days, respectively, in MC3T3E1-BIG-3 clones, relative to MC3T3E1-EV clones. This increase in cAMP production was associated with an increase in PTH binding. Expression of BIG-3 increased mRNA levels encoding Cbfa1, type I collagen, and osteocalcin and accelerated formation of mineralized nodules. In conclusion, we have identified a novel WD-40 protein, induced by BMP-2 treatment, that dramatically accelerates the program of osteoblastic differentiation in stably transfected MC3T3E1 cells.
Bone formation in vivo occurs via two major processes, intramembranous and endochondral ossification. Although endochondral bone formation in vivo and in vitro has been the focus of several studies, the molecular signals that control this process remain to be defined. A number of factors have been shown to play a critical role in endochondral bone formation including transforming growth factor-␤ superfamily members, notably the subfamily of the bone morphogenetic proteins (BMPs) 1 (1, 2) . BMPs have high homology to decapentaplegic (dpp) and to Vg-1, which are responsible for early embryo pattern formation in Drosophila and Xenopus, respectively (1) . BMPs are expressed in a spatial and temporal pattern during embryogenesis in vertebrates and are required for the development of many organs and tissues, including the lung, kidney, eye, testis, teeth, skin, and heart (3). They are also expressed at sites of new bone formation early in development, suggesting that they are key signaling molecules for limb formation and patterning as well as for osteogenesis (3) (4) (5) . BMPs were originally identified as bone-derived factors capable of inducing ectopic bone formation when injected subcutaneously in animal models (6, 7) . In vitro, BMPs and, in particular BMP-2, have been reported to induce the expression of many osteoblast genes (8 -15) .
Using differential display PCR, we have identified a novel gene 3 kb long, named BIG-3 (BMP-2-induced gene 3 kb), which is induced as a prechondroblastic cell line, MLB13MYC clone 17 (15) , and acquires markers of the osteoblast phenotype in response to BMP-2 treatment. When treated with BMP-2, these cells rapidly lose chondrocytic markers and express osteoblastic markers including type I collagen and osteocalcin mRNA (15) . Because the BMP-2-induced expression of osteoblastic markers by MLB13MYC clone 17 cells parallels molecular events seen during endochondral bone formation in vivo, these cells are a suitable model for identifying genes regulated by BMP-2 during endochondral bone formation.
BIG-3 encodes a novel 34-kDa protein belonging to the family of WD-40 repeat proteins. This family of proteins has been shown to play a role in numerous cellular functions including signal transduction, mRNA processing, gene regulation, vesicular trafficking, and regulation of the cell cycle (16 -18) . Structurally, these proteins contain a conserved Trp-Asp motif (the so-called WD-40 repeat), which contains the GH dipeptide at the N terminus and the WD dipeptide at the C terminus separated by a region of variable length (16, 17) . The best characterized WD repeat protein is the ␤-subunit of the G proteins, which contains seven WD-40 repeats (19, 20) . Similar repetitive motifs have been found in a number of other proteins with apparently unrelated cellular functions such as a mammalian coatamer ␤-subunit, a component of a cytosolic protein complex that associates with Golgi membranes (21), the Drosophila protein Groucho, which is involved in neurogenesis (22) and several yeast proteins including STE4, a component of the pheromone response pathway (23); Tup1, a repressor of histone gene transcription (24 -26) ; MSI1, a negative regulator of RASmediated cAMP synthesis (27) ; PRP4, which plays a role in RNA splicing (28, 29) ; and CDC4, required for initiation of DNA replication (30) . However, none of the members of the WD-40 family of proteins has been shown to play a role in the regulation of endochondral bone formation.
Because BIG-3 was regulated by BMP-2 and was expressed in cells of the osteoblastic lineage in vitro, we undertook studies to identify a functional role for BIG-3 in the program of osteoblast differentiation. The murine cell line, MC3T3-E1, was chosen for these studies because it has features of preosteoblasts and is thought to recapitulate the program of osteoblast differentiation when cultured for prolonged periods in the absence of differentiating agents such as BMP-2.
EXPERIMENTAL PROCEDURES
Cell Culture-The prechondroblastic cell line MLB13MYC clone 17 was maintained as reported previously (15) . At confluence, the cells were treated with 0, 200, and 500 ng/ml BMP-2 (Genetics Institute, Cambridge, MA) in Dulbecco's modified Eagle's medium, 1% heat-inactivated-fetal calf serum, and 1% penicillin/streptomycin (Life Technologies, Inc.) for 8 -72 h. All cells were harvested 72 h after confluence. Conditionally immortalized murine bone marrow stromal cells, osteoblasts, osteocytes, and growth plate chondrocytes (Dr. F. R. Bringhurst, Massachusetts General Hospital, Boston, MA) were cultured as reported previously (31) (32) (33) . Total RNA was isolated from cells cultured for 5 days under differentiating conditions. Primary calvarial osteoblasts from 18.5 dpc embryos were isolated and cultured as described previously (32) . MC3T3E1 cells, obtained from ATCC, were cultured in ␣-minimal essential medium, 10% fetal bovine serum, and 1% penicillin/streptomycin for periods ranging from 3 to 35 days. In experiments assessing mineralization, medium was supplemented with ␤-glycerol phosphate and ascorbic acid (34) (Sigma). Fresh medium was added twice a week.
Differential Display (dd) PCR-Total RNA, isolated from MLB13MYC clone 17 cells (Tri reagent, Sigma) treated with BMP-2 (200 and 500 ng/ml) for 8, 16, or 24 h, was first treated with RNase-free DNase I to eliminate contaminating chromosomal DNA (MessageClean ® kit, GenHunter Corp, Nashville, TN). Total RNA isolated from parallel untreated cultures was used as control for each time point. Two independent ddPCR reactions were performed according to the manufacturer's instructions (RNAimage ® kit, GenHunter Corp, Nashville, TN). The radioactive PCR products were resolved on denaturing 6% polyacrylamide/urea sequencing gels. After overnight autoradiography, differentially expressed bands were identified by comparison of ddPCR products representing cDNA species from BMP-2 treated and untreated cells. ddPCR products that were reproducibly differentially expressed were excised from the gel, reamplified, and subcloned into PGEM-T easy (Promega, Norwalk, CT).
Northern Analysis-Ten g of total RNA (or two g of poly(A) ϩ mRNA for osteocalcin detection) was isolated from the cell types indicated and from tissues of a 3-month-old male C57BL6 mouse, was resolved on a 1% agarose/formaldehyde gel and transferred to a nylon membrane (Biotrans ICN, Aurora, OH) by capillary blotting. Probes were radiolabeled with [␣- dehyde-3-phosphate dehydrogenase verified that equal amounts of RNA were loaded.
Cloning and Sequencing-To obtain the full-length cDNA sequence of BIG-3, a cDNA library engineered using mRNA isolated from BMP-2-treated MLB13MYC clone 17 cells was screened. Screening of 1 ϫ 10 6 plaque-forming units resulted in the isolation of three independent clones. The cDNA inserts and pBluescript were excised from the phage using Ex Assist helper phage (Stratagene, La Jolla, CA). The full-length sequence was obtained by sequencing both strands of the three clones.
Immunohistochemistry-A peptide, LENDKTIKLWKSDC, selected as an epitope using the Jameson-Wolf antigenicity index, was conjugated to keyhole limpet hemocyanin (Massachusetts General Hospital, Peptide Core Facility) and used to immunize rabbits (Covance, Denver, PA). Following affinity purification of serum on a peptide column, the purified anti-BIG-3 was used for immunohistochemistry. Calvariae from 14.5 to 18.5 dpc embryos were fixed in 10% buffered formalin, followed by dehydration and paraffin embedding. Tissue blocks were cut into 6-m sections, deparaffinized, and rehydrated. After incubation with 3% H 2 O 2 to block endogenous peroxidase activity, immunohistochemistry was performed using the TSA Biotin system kit (PerkinElmer Life Sciences). Briefly, slides were incubated with anti-BIG-3 or with a nonimmune rabbit IgG at room temperature for 1 h, followed by rinses and addition of a biotinylated anti-rabbit IgG (Vector Laboratories, Inc., Burlingame, CA) for 30 min at room temperature. After incubation with streptavidin-horseradish peroxidase for 30 min at room temperature, slides were treated with biotinyl tyramide for 5 min. Immunoreactive proteins were then visualized using streptavidin-fluorescein and streptavidin-Texas Red.
Stable Transfection-MC3T3-E1 cells were plated at a density of 3 ϫ 10 3 cells/cm 2 . After 24 h they were stably transfected with the fulllength coding region of BIG-3 (MC3T3E1-BIG-3) cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA) or with the empty vector (MC3T3E1-EV) using calcium phosphate precipitation. After 24 h, and every 48 h thereafter, the medium was replaced with fresh medium containing 300 g/ml of G418 for 14 days. This G418 dose was demonstrated to kill 100% of untransfected cells in 10 days. Three independent pools of 8 -12 clones of MC3T3E1-BIG3 and MC3T3E1-EV were isolated. Pools of clones between passages 2 and 5 were used for the experiments reported.
Cell Proliferation-MC3T3E1-EV and MC3T3E1-BIG-3 pooled clones were plated at a density of 5 ϫ 10 3 cells/cm 2 and cultured for periods ranging from 2 to 7 days. At each time point, cells were harvested and counted using a hemocytometer. Duplicate measurements were performed on four independent wells for each time point.
Alkaline Phosphatase Activity-MC3T3E1-EV and MC3T3E1-BIG-3 pooled clones were plated at a density of 5 ϫ 10 3 cells/cm 2 and cultured for periods ranging from 3 to 25 days. At each time point, the alkaline phosphatase activity in cell lysates was assessed in assay buffer (50 mM Tris-HCl, pH 7.6, and 0.1% Triton X-100) containing 1.5 M 2-amino-2-methyl-1-propanol for 1 h at 37°C using p-nitrophenyl phosphate as a substrate. The release of p-nitrophenol was monitored by measuring absorbance at 405 nm.
Cyclic AMP Accumulation-MC3T3E1-EV and MC3T3E1-BIG-3 pooled clones were plated at a density of 5 ϫ 10 3 cells/cm 2 and cultured for periods ranging from 5 to 25 days. To assess basal and agonistinduced cyclic AMP accumulation, cells were rinsed twice with assay buffer (Dulbecco's modified Eagle's medium containing 2 mM isobutylmethylxanthine, 1 mg/ml bovine serum albumin, 35 mM HEPES-NaOH, pH 7.4) and then incubated for 15 min at 37°C in the presence or absence of agonist. After removal of the buffer, the plates were immediately frozen on dry ice. The frozen cells were thawed directly into 0.25 ml of 50 mM HCl and cAMP in the acid extracts was measured using a cAMP radioimmunoassay kit (PerkinElmer Life Sciences) as described previously (35) .
Radioligand Binding-MC3T3E1-EV and MC3T3E1-BIG-3 pooled clones were plated at a density of 50 ϫ 10 3 cells/cm 2 and cultured for periods ranging from 7 to 21 days. Measurement of PTH 1 receptorspecific binding was performed as described previously (36) . In brief, cell monolayers in 24-well dishes were washed twice with 0. Western Analysis-MLB13MYC clone 17 cells were plated at a density of 2.5 ϫ 10 4 cells/cm 2 and treated with 0 or 200 ng/ml BMP-2 for 24 h. Pooled MC3T3E1-EV and MC3T3E1-BIG-3 clones were plated at a density of 5 ϫ 10 3 cells/cm 2 and cultured for periods ranging from 3 to 30 days. Cells were lysed in 25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton, and 10 g of protein was subjected to SDS-polyacrylamide gel electrophoresis under reducing conditions. After transfer to Hybond ECL (Amersham Pharmacia Biotech) membranes were blocked in phosphate-buffered saline containing 1% bovine serum albumin and 5% nonfat dry milk for 1 h at room temperature. Immunodetection was performed by incubating with anti-BIG-3 at room temperature for 1 h, followed by rinses and addition of a peroxidase-conjugated mouse antirabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA). Immunoreactive proteins were visualized using a chemiluminescence detection kit (PerkinElmer Life Sciences) according to the manufacturer's instructions.
Measurement of Mineralized Matrix Formation and Calcium Accumulation-MC3T3E1-EV and MC3T3E1-BIG-3 pooled clones were plated at a density of 5 ϫ 10 3 cells/cm 2 and cultured for periods ranging from 14 to 35 days. The formation of mineralized matrix nodules was assessed by Alizarin Red S staining (14) . For quantitative assessment, the Alizarin Red S dye was eluted and measured spectrophotometrically (14) .
Statistical Analyses-All values are expressed as mean Ϯ S.E. Multiple measure analysis of variance (ANOVA) was used to evaluate differences between the values obtained from MC3T3E1-BIG-3 cells and their respective controls. Student's paired t test was used to evaluate differences between MC3T3E1-BIG-3 pools and MC3T3E1-EV pools at each time point. A p value of Ͻ0.05 was considered statistically significant.
RESULTS
Total RNA, isolated from MLB13MYC clone 17 cells treated with 0, 200, or 500 ng/ml BMP-2 for 8, 16, and 24 h, was used for ddPCR experiments. After overnight autoradiography, bands representing differentially expressed mRNAs were identified. One of the differentially expressed PCR products (Fig.  1A, arrow) was excised, reamplified, and used as a probe in Northern analyses to confirm differential expression (data not shown). The ddPCR product was then subcloned into pGEM T-easy. Northern blots, probed with this subcloned cDNA, detected a single mRNA transcript of 3 kb (Fig. 1B) , which was induced 3.5-fold after 24 h of BMP-2 treatment of MLB13MYC clone 17 cells, relative to cells left untreated. The sequence of this ddPCR product did not correspond to any known genes in the NCBI BLAST data base. We named this cDNA BIG-3 (for BMP-2-induced gene 3 kb). Because MLB13MYC clone 17 cells have features of prechondroblastic cells and, upon BMP-2 treatment, acquire features of osteoblasts (15), we next investigated whether selected chondrocyte and osteoblast cell lines express BIG-3. The BIG-3 transcript was detected in RNA isolated from conditionally immortalized murine bone marrow stromal cells, osteoblasts, and osteocytes isolated from 18.5 dpc embryos (all cultured under differentiating conditions), as well as in RNA isolated from calvaria and primary calvarial osteoblasts from 18.5 dpc embryos ( Fig. 2A) . BIG-3 expression was also detected in differentiated conditionally immortalized murine growth plate chondrocytes, and 96 h of BMP-2 treatment (100 ng/ml) increased BIG-3 mRNA levels by 4-fold in these cells, relative to cells left untreated for 96 h (Fig. 2B ). BIG-3 mRNA was also present in ROS 17/2.8 osteosarcoma cells but was not detected in murine fibroblasts (data not shown). As shown in Fig. 2C , BIG-3 mRNA was present in several mouse tissues, with testis exhibiting the highest levels.
The full-length cDNA sequence for BIG-3 was obtained by screening, a MLB13MYC clone 17 cDNA library using the 210-base pair ddPCR product as a radiolabeled probe. The screening of 1 ϫ 10 6 plaque-forming units resulted in the isolation of three independent overlapping phage clones. GenBank data base analysis of the full-length sequence (2921 base pairs; accession no. AF416510) (Fig. 3A) revealed that BIG-3 did not encode a gene with a known function. This sequence was highly homologous (Ͼ87%) to several partial human cDNAs of unknown function (BC001635, AHS011376, AK025810, and AK000552). The deduced 328-amino acid sequence (Baylor College of Medicine, Houston, TX) (Fig. 3A) had a calculated molecular mass of ϳ34 kDa composed largely of WD-40 repeats (ExPASY). Molecular modeling (Rasmol) confirmed a propeller structure, for these seven repeats, characteristic of the family of WD repeat proteins (Fig. 3B) .
Because BIG-3 was expressed in vitro by cells of the osteoblastic lineage, we performed immunohistochemistry to determine whether osteoblasts express BIG-3 in vivo. BIG-3 protein was present in osteoblasts of fetal mouse calvariae from 14.5 to 18.5 dpc (Fig. 4, 15.5 dpc) .
Because BIG-3 was expressed in vitro and in vivo by cells of the osteoblastic lineage, we investigated whether this novel gene could alter the program of osteoblastic differentiation in the murine osteoblast cell line MC3T3-E1. MC3T3-E1 cells were chosen because they have features of preosteoblasts and recapitulate the program of osteoblast differentiation when cultured for prolonged periods in the absence of exogenous differentiating agents such as BMP-2. These cells were, therefore, stably transfected with the full-length coding region of BIG-3 (MC3T3E1-BIG-3) or with the empty vector (MC3T3E1-EV) and selected markers of osteoblastic differentiation were assessed.
The acquisition of the mature osteoblast phenotype is characterized by the ability of these cells to synthesize alkaline phosphatase, and an increase in the specific activity of this enzyme is directly correlated with a shift to a more differentiated state (37) . Therefore, three independent pools of 8 -12 clones of both MC3T3E1-BIG-3 and MC3T3E1-EV were examined for the time course of onset, and magnitude of increase, in alkaline phosphatase (AP) activity. In the MC3T3E1-EV pools, AP activity did not increase significantly until 11 days (p Ͻ 0.0005 by Student's t test). However, a significant increase was seen in all MC3T3E1-BIG-3 pools at 7 days (p Ͻ 0.005 by Student's t test), and, by 14 days, the cells transfected with BIG-3 had a 10-fold increase in AP activity relative to MC3T3E1-EV pools (p Ͻ 0.00001 by Student's t test) (Fig. 5) . Although the alkaline phosphatase activity rose significantly in the MC3T3E1-EV pools over time, at 25 days the MC3T3E1-BIG-3 pools maintained a 4-fold higher activity (p Ͻ 0.00001 by Student's t test) (Fig. 5) . No statistically significant differences were observed within the three pools of MC3T3E1-BIG-3 clones or the three MC3T3E1-EV pools.
The receptor for parathyroid hormone (PTH 1 receptor) has been shown to be induced during osteoblastic differentiation (38, 39) . Cyclic AMP production in response to PTH, an indicator of PTH 1 receptor activity, was increased 10-and 14-fold at 7 days and 14 days, respectively, in the three independent pools of 8 -12 clones of MC3T3E1-BIG-3, relative to the three independent MC3T3E1-EV pooled clones (Fig. 6A) . No statistically significant differences were observed at any time point within the three pools of MC3T3E1-BIG-3 or the three pools of MC3T3E1-EV clones. Cyclic AMP production in response to forskolin was also increased in the pooled MC3T3E1-BIG-3 clones compared with the MC3T3E1-EV pooled clones (Fig.  6A) . However, when the clones were cultured for longer time points (18 days through 25 days), no difference in the cyclic AMP response to forskolin was observed between the pooled clones of MC3T3E1-BIG-3 and MC3T3E1-EV pools (data not shown), although cAMP production in response to PTH remained markedly elevated in the MC3T3E1-BIG-3 clones. Because no statistically significant differences were observed within the three MC3T3E1-EV pooled clones or within the three MC3T3E1-BIG-3 pooled clones, the first pool of MC3T3E1-EV and MC3T3E1-BIG-3 clones was used to evaluate PTH binding. As shown in Fig. 6B , an increase in PTH binding was observed in MC3T3E1-BIG-3 pooled clones relative to MC3T3E1-EV pooled clones. This difference was already present after 7 days in culture (Fig. 6B ) and persisted at 21 days (data not shown). The apparent K D was similar to that reported previously for MC3T3-E1 cells (40) , suggesting that the increase in PTH binding reflects an increase in receptor number rather than an increase in affinity. Examination of other specific molecular markers of osteoblast differentiation (41) (42) (43) ) demonstrated a dramatic increase in mRNA encoding Cbfa1, type I collagen (Fig. 7) , and osteocalcin (data not shown) in the MC3T3E1-BIG-3 clones compared with the MC3T3E1-EV clones. Stable expression of BIG-3 did not alter the proliferation of MC3T3-E1 cells, as assessed by counting pooled clones at regular intervals from the time of plating until they achieved confluence (data not shown).
Dramatic overexpression of proteins can result in a phenotype that reflects interference with normal cellular actions, rather than enhancing the normal effects of the protein of interest. We, therefore, performed Western analyses to examine the degree of overexpression of BIG-3 in MC3T3E1-BIG-3 clones, relative to the MC3T3E1-EV clones. As shown in Fig.  8A , at 3 days after plating, the pooled clones stably transfected with BIG-3 expressed 2-fold more BIG-3 protein that the MC3T3E1-EV pooled clones. This modest degree of overexpression was not observed at later time points, being masked by the dramatic increase in the endogenous BIG-3 protein that was observed in the MC3T3E1-EV clones as they recapitulate the program of osteoblast differentiation during prolonged culture. This increase in BIG-3 protein levels seen at 3 days in the MC3T3E1-BIG-3 clones was similar to the increase in the levels of endogenous BIG-3 after 24 h of BMP-2 treatment of the MLB13MYC clone 7 cells (Fig. 8B) .
The final step in the program of osteoblast differentiation is thought to be the formation of mineralized bone nodules. We, therefore, investigated whether stable expression of BIG-3 accelerated the formation of mineralized nodules. Mineralized nodules were first seen at 21 days in the MC3T3E1-BIG-3 clones, 14 days before they were detectable in the MC3T3E1-EV clones (data not shown). Quantitation of mineral deposition by elution of Alizarin Red S from stained mineral deposits at 25 days, demonstrated a 3-fold increase in the dye content of the MC3T3E1-BIG-3 clones compared with MC3T3E1-EV clones (Fig. 9) . The mineral deposition by the MC3T3E1-EV and MC3T3E1-BIG-3 pooled clones continued to increase with more prolonged culture (Fig. 9) ; however, at 35 days the MC3T3E1-BIG-3 clones still had 2-fold increase in dye content relative to MC3T3E1-EV clones. DISCUSSION We have identified a novel gene, named BIG-3, that is expressed in numerous mouse tissues and in cells of both the osteoblastic and chondrocytic lineages. This gene encodes a 328-amino acid protein with a molecular mass of ϳ34 kDa. BIG-3 is a new member of a family of highly conserved proteins, the WD-40 repeat proteins, found in all eukaryotes but not in prokaryotes (16, 17) . Proteins in the WD-40 family contain 4 -16 conserved WD-40 repeats, characterized by a variable length region followed by a core sequence delimited by two characteristic dipeptides, GH and WD (16 -18) . The most highly conserved feature of the WD repeat proteins is an aspartic acid residue 6 positions N-terminal to the WD, present in 86% of WD repeats (44) and found in all of the BIG-3 repeats. Of the WD repeats present in the members of this family, at least one WD repeat must match the amino acid consensus with one or fewer mismatches and at least one other repeat with three or fewer mismatches must be present (16) . BIG-3 has two perfect repeats, two with one mismatch, two with two mismatches, and one with four mismatches.
The most extensively characterized WD repeat protein is the G protein ␤-subunit, which, like BIG-3, contains seven WD repeats (19, 20) . The tertiary structure of the G protein ␤-subunit demonstrates that each of the seven WD repeats folds into four antiparallel ␤-strands radiating outward from a central axis (19) , leading to the description of "␤-propeller." Computerized structure homology searches confirm that BIG-3 is closely related to the G-protein ␤-subunit as well as to Tup1 (45) , which forms a corepressor complex with Ssn6, regulating at least 3% of the genes expressed in Saccharomyces cerevisiae (24, 25) . Although the structure of BIG-3 is homologous to that of Tup1, closer examination of the primary sequence reveals that only repeats 1 and 3 are highly conserved; there are significant gaps in the "noncore" regions of the repeats and BIG-3 lacks a glutamine-rich region characteristic of Tup1 and other transcriptional regulatory proteins (Fig. 10) . These data suggest that BIG-3 is not the mammalian homolog of this important transcriptional repressor. The absence of a coiledcoil structure and of primary sequence homology in the short amino-terminal extension of BIG-3 suggests that it is not closely related to the G protein ␤-subunit subfamily (Fig. 10) . The search for homologs of BIG-3, based on its primary amino acid sequence, confirmed that this protein was novel, suggesting that BIG-3 may represent the first member of a subfamily of WD-40 proteins for which actions and co-mediators have not yet been characterized.
The WD-40 family of proteins participates in a wide variety of cellular functions including signal transduction, mRNA processing, gene regulation, and the cell cycle (16, 18) . BIG-3 did not alter the proliferation rate of MC3T3-E1 cells but dramatically accelerated the rate of osteoblast differentiation. We, therefore, postulate that the 2-fold increase in BIG-3 protein observed at 3 days in MC3T3E1-BIG-3 clones is sufficient to initiate an acceleration in the program of osteoblastic differentiation. Similar to other proteins involved in cellular differentiation, the level of BIG-3 protein decreases once the MC3T3-E1 cells are terminally differentiated and mineralize. Because the WD-40 repeat proteins are involved in recruitment of other proteins, it is likely that the ␤-propeller structure of BIG-3 is involved in the assembly of a multimeric protein complex that interacts with novel or known osteogenic factors and thereby modulates the process of osteoblast differentiation. To date there is no consensus role for the non-WD-40 repeat sequences. Some of the amino-and carboxyl-terminal regions of the peptides have been shown to be important for the function of the protein, e.g. the glutamine-rich amino-terminal extension of Tup1 is important for its role as transcription factor (46) , and the binding of the amino terminus of the G protein ␤-subunit to the ␥-subunit is essential for its secondary structure and resultant activity (47) . Similarly, the first 40 amino acids of BIG-3 may serve to recruit additional factors to the complex or, alternatively, to tether the propeller region, thus determining subcellular localization.
Clarification of the role of the amino-terminal extension of BIG-3 and characterization of the complex recruited by its ␤-propeller are likely to unveil additional novel factors that contribute to the regulation of osteoblastic differentiation in the developing and maturing skeleton.
